"Our alliance with Luminis Partners is an important component of our broader international focus to provide clients with strategic opportunities,” said Mark Van Lith, CEO of Guggenheim Securities. "We ...

Guggenheim initiated coverage of Sportradar (SRAD) with a Buy rating and $27 price target Discover the Best Stocks and Maximize Your Portfolio: ...

Guggenheim reaffirmed their buy rating on shares of CyberArk Software (NASDAQ:CYBR – Free Report) in a research note issued ...

Walmart (NYSE:WMT – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Guggenheim in a research report issued on Monday,Benzinga reports. They currently have a $100.00 ...

Marvel announces the Bring on the Bad Guys event crossover, which occurs across seven one-shots headlined by its most iconic ...

From sweeping curves to industrial structures, visionary architects have reimagined museums as more than just spaces to view ...

Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.

Investing.com -- Maze Therapeutics Inc (NASDAQ: MAZE ) received bullish coverage from multiple analysts, with Guggenheim, ...